SAN ANTONIO, March 17, 2026--bioAffinity Technologies' new patient case study demonstrates the benefit of CyPath Lung in ...

bioAffinity Technologies Inc BIAF shares are trading higher on Tuesday morning. The move follows the release of a new ...

Pulmonary involvement is highly prevalent in individuals with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), affecting 82.7% of patients with granulomatosis with polyangiitis ...

The stock jumped on heavy volume after a positive update tied to its AI-driven lung cancer screening test.

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

Health systems can transition from small-scale artificial intelligence pilots to high-speed, validated rollouts that meaningfully improve patient outcomes by maintaining three key guardrails, ...

Study confirms 96.7% overall diagnostic yield due to precise lesion targeting using digital tomosynthesis and augmented fluoroscopy with CBCT verification ...

A young woman steps nervously into a makeshift screening tent. Inside, a small tripod-mounted thermal camera waits. Asked to ...

I heard it in several settings from family medicine clinic to a thoracic surgery operating room, from different levels of the ...

Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD ...

Cool Choices is a free four-week online game that helps Wisconsin schools boost student engagement while saving resources and ...